Five Star Equities expects large pharmaceuticals to explore acquiring biotechnology firm Rosetta Genomics Ltd. (Nasdaq: ROSG) sending the stock price leaping $3.81 to close at $11.24.
Rosetta Genomics Prime Target For Acquisition
May 23, 2012 at 17:52 PM EDT
